4.6 Article

Dysregulation of Pulmonary Responses in Severe COVID-19

期刊

VIRUSES-BASEL
卷 13, 期 6, 页码 -

出版社

MDPI
DOI: 10.3390/v13060957

关键词

COVID-19; TH17; IgA; type I interferon; PAI-1

类别

资金

  1. NIH [AI142200, HL148337]

向作者/读者索取更多资源

Patients with severe COVID-19 exhibit different cellular composition in bronchoalveolar lavage fluid compared to those with mild disease, with changes in immune cell numbers and activity that may contribute to severe pulmonary pathology. Additionally, IFN-I and PAI-1 have been proposed as potential biomarkers to predict susceptibility to severe COVID-19.
Patients with coronavirus disease 2019 (COVID-19) predominantly have a respiratory tract infection with various symptoms and high mortality is associated with respiratory failure second to severe disease. The risk factors leading to severe disease remain unclear. Here, we reanalyzed a published single-cell RNA-Seq (scRNA-Seq) dataset and found that bronchoalveolar lavage fluid (BALF) of patients with severe disease compared to those with mild disease contained decreased TH17-type cells, decreased IFNA1-expressing cells with lower expression of toll-like receptor 7 (TLR7) and TLR8, increased IgA-expressing B cells, and increased hyperactive epithelial cells (and/or macrophages) expressing matrix metalloproteinases (MMPs), hyaluronan synthase 2 (HAS2), and plasminogen activator inhibitor-1 (PAI-1), which may together contribute to the pulmonary pathology in severe COVID-19. We propose IFN-I (and TLR7/TLR8) and PAI-1 as potential biomarkers to predict the susceptibility to severe COVID-19.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据